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Highlights: 
 Immunocapture of E. coli in FEP microcapillaries reported for first time 
 Identified the key role of interrogation volume and gravity settling 
 Up to 100% of E. coli cells were captured with a limit of detection of just 1 colony 
forming unit (CFU) 
 Immunospecificity was shown by performing ELISA with a different bacterial specie 
Abstract 
This study presents novel experimental insights into the direct quantitation and immunocapture 
of bacteria cells in a fluoropolymer microcapillary array, using Escherichia coli as work model, 
a pathogen responsible for around 80% of urinary tract infections (UTIs). In spite of the current 
clinical demand for sensitive tests for rapid identification and quantitation of pathogens in 
human samples, portable diagnostic tests developed to date lack the specificity, limit of 
detection and speed for effective implementation in bacteria detection at point-of-care. The 
‘open microfluidic’ approach presented in this work directly addresses those challenges. We 
report for the first time evidence of immunocapture of bacteria using polyclonal antibodies 
immobilized on the inner surface of an inexpensive 10-bore, 200 m internal diameter FEP-
Teflon® MicroCapillary Film, with a limit of detection (LoD) of at just 1 colony forming unit 
(CFU). In capillaries coated with less than a full monolayer of capture antibody, we observed 
a first order equilibrium, with bacteria captured (in CFUs/ml) linearly proportional to the CFU/ml 
in the incubated sample. We captured up to 100% of E.coli cells, with clear evidence of 
immunospecificity as demonstrated by testing with a different bacteria specie (in this case 
Bacillus subtillis). We noticed gravity settling of bacteria within the capillaries created a 
gradient of concentration which on the overall enhanced the capturing of cells up to 6 orders 
of magnitude beyond the theoretic full monolayer (4.5×104 CFUs/ml), which washings having 
an unnoticeable effect. Our data particularly highlights quantitatively the relevance of 
interrogation volume in respect to the miniaturisation of bacteria quantitation, which cannot be 
solved with the most sophisticated imaging equipment. A further set of continuous flow 
experiments at a flow rate of just 1 μl/min (corresponding to a wall shear rate of 101 s-1 and AC
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superficial flow velocity 53 µm/s) showed a degree of flow focusing, yet the mobility, antibody 
affinity capturing and gravity settling of bacteria cells enabled successful capturing in the 
microcapillaries. These results will inform the future development of effective microfluidic 
approaches for rapid point-of-care quantitation of bacterial pathogens and in particular rule-in 
or E. coli in UTIs. 
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1. Introduction 
Bacterial infections represent a significant burden to global health and economy. It is 
estimated that multidrug resistance ‘superbugs’ is responsible for around 25.000 deaths per 
year in Europe resulting annually in healthcare costs of €1.5 billion and significant productivity 
losses [1]. Although treatable, most diseases caused by bacterial infections including 
Escherichia coli are the cause of high annual mortality rate in both developing and developed 
countries. Difficulty in early identification of pathogens and inaccurate treatment remain the 
two major clinical challenges to be solved [2,3]. Bacterial identification at point-of-care (POC) 
has proved particularly difficult, with no rapid and cost-effective tool yet available to identify 
and quantify pathogens with the high sensitivity and specificity required for clinical use. 
Identification of pathogens is currently done in centralised microbiology laboratories, involving 
complex logistics and long waiting times, typically between 20 and 72 hr [4,5]. New diagnostics 
tools for rapid bacteria identification and quantitation are regarded essential for managing the 
over prescription of antibiotics and tackling antimicrobial resistance [6,7,8]. Consequently, 
microfluidic detection of pathogen is emerging as a new solution to tackle bacterial infections, 
offering high throughput combined with small fluid volumes and short assay time in a portable 
format compatible with POC requirements [2,9,10]. However, development of those devices 
remains mostly empirical, driven from an analytical chemistry perspective that is disconnected 
to the engineering challenges represented by e.g. the high-shear and focused flow of bacteria 
in microchannels or microcapillaries. 
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Methods currently available for bacterial detection are based on a variety of laboratory-
based tests including microscopy [11], plate culture [4], antimicrobial peptides [9], 
immunoassays [4,7], nucleic-acid amplification [7,11], electrochemical impedance microscopy 
[7] and magnetic beads [11]. Though well established, some of those techniques present 
relevant drawbacks for application at POC such as complex sample preparation, expensive 
reagents, lack of specificity and sensitivity and/or demanding expensive readout systems only 
available in sophisticated centralized labs [3,10-12]. Microbiological identification of bacteria 
intrinsically relies on the doubling time and growth time of bacteria in agar-rich plates, which 
is set by the nature of the microorganism and growth conditions. Immunoassays are highly 
sensitive bioanalytical tools that rely on the high antibody specificity and can be used in several 
applications including clinical diagnostics [2,5,10,13,14], environmental monitoring [10,15], 
bioterrorism [3] and drug kinetics [3,10] for pharmacology industry. They utilise enzymatic 
amplification for detection of very low concentrations of proteins or bacteria, so several authors 
have attempted detection of bacteria with immunoassays [2,5,10,13-17]. Miniaturization of 
bacteria detection tests presents the problem of reduced signal strength which demands very 
sophisticated detection and quantitation equipment. This is one of the biggest challenges for 
POC microfluidic devices [10,18,19]. Limitations reported for immunoassay detection of 
4
bacteria are the poor sensitivity, cross-reactivity, reproducibility and reduced limit of detection 
(LoD) [20,21]. So far there has been no systematic study showing how the miniaturisation and 
immunoassay format affects the performance of an immunoassay aiming rapid POC bacteria 
quantitation. 
In this study we used optical imaging techniques such as Laser Scanning Confocal 
Microscopy (LSCM) and Scanning Electron Microscopy (SEM) to understand immunocapture 
of bacteria in plastic microcapillaries coated with a polyclonal antibody. We used E.coli K12 
fluorescently labelled to gather quantitative information about avidity of antibody-bacteria 
binding [9,22]. Plastic microcapillaries offer large surface-area-to-volume ratio (SVR), are 
inexpensive and enable larger volumes of sample to be used typical of ‘open’ microfluidics. 
We employed a new cheap miniaturised immunoassay platform based on a 10-bore 
Microcapillary film (MCF) melt-extruded from Fluorinated ethylene propylene (FEP-Teflon®). 
MCF detection present optical characteristics that favour high signal-to-noise-ratio and simple 
optical detection with low-cost readout systems, essential for high performance detection in 
an affordable, portable format. The hydrophobic surface of FEP microcapillaries allows simple 
antibody immobilization by passive adsorption and avoids complex fluid handling [23]. The 
large SVR ratio of 200m microcapillaries enabled a performance comparable to microtiter­
based immunoassays with at >10-fold reduction in total assay time [24]. These features were 
key to our recent MCF developments: PSA biomarker detection using smartphone based 
system and screening from whole blood [24,25] multiplexed femtomolar quantitation of human 
cytokines (IL-1β, IL-6, IL-12 and TNF-α) [26]; Lab on a stick for multi-analyte cellular assays 
as antibiotic susceptibility and microbiological screening [27] and one-step quantitation of PSA 
using nanoparticles labels [28]. 
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2. Experimental 
2.1. Reagents and materials 
Unconjugated Rabbit Polyclonal Antibody Immunogen: O and K antigenic serotypes (all 
types) of Escherichia coli (# PA1-7213); LB Agar, Miller (# BP1425-2) and LB Broth, Miller 
(Granulated) (# BPE9723-2) were supplied by Fisher Scientific UK Ltd, Loughborough, UK). 
Phosphate Buffered Solution, 0.01M at pH 7.4 (PBS, # P5368-10PAK), washing buffer PBS 
with 0.05% v/v of Tween-20, Nunc maxisorp ELISA 96-well MTPs and SIGMAFASTTM OPD 
(o-Phenylenediamine dihydrochloride) tablets (# P9187) were sourced from Sigma Aldrich 
(Dorset, UK). Pierce™ Protein-Free Tris-Buffered Saline (TBS) Blocking Buffer (# 37584), 
LIVE/DEAD® BacLight™ Bacterial Viability Kit, for microscopy (# E2069) and High Sensitivity 
Streptavidin–HRP (# 21130) were supplied by Thermo Scientific (Northumberland, UK). 
Female Luer ¼ (# P-624) were obtained from C M Scientific (Silsden, UK). A 10-bore MCF 
material and push-fittings seals were provided by Lamina Dielectrics Ltd (Billingshurst, UK). 
5
MCF fittings were designed by Lamina Dielectrics Ltd and manufactured in-house. E.coli K12 
‘wild-type’ (NCIMB 11290) and Bacillus subtillis (NCIMB 8054) were supplied by 
Loughborough University, obtained from NCIMB Ltd, (Aberdeen, UK). 
2.2. Fluoropolymer MCF 
A 10-bore MCF was used (see Figure 1) which presents a parallel array of microcapillaries 
with a mean hydraulic diameter of 206 ± 12.6 μm and external dimensions 4.5 ± 0.10 mm width 
and 0.6 ± 0.05 mm thickness [23]. This material was manufactured by a novel melt-extrusion 
process from Teflon® FEP (Dow, USA) [23,25]. The cost for pelleted FEP material is in range 
of £20/Kg, with a unit weight of 5 grams per meter of material, meaning the material cost for a 
10-plex, 50 mm long MCF test strip is less than 1 pence. This excludes the cost of reagents, 
manufacturing and fittings required for carrying out immunoassays in the MCF. FEP was 
chosen for its excellent transparency resulting from refractive index matching with water, 
allowing good signal-to-noise detection with low cost readout systems [23] but also with 
sophisticated fluorescence imaging equipment such as confocal microscope. 
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2.3. E.coli sample preparation 
A colony of Escherichia coli K12 “wild type’’ was inoculated in a 100 mL LB broth and 
incubated at 37 ºC overnight under sterile conditions. Afterwards the culture media was 
washed 3 times with PBS buffer and cells recovered after centrifugal separation (4,500 rpm, 
20 min) and re-suspended in the original volume. E.coli sample aliquots were prepared in 2 ml 
Eppendorf tubes with an OD600 of 0.7 and stored at 20 ºC. Serial dilutions were made from a 
volume of 0.1ml E.coli samples in 0.01 M PBS and spread onto LB agar plates at 37 ºC 
overnight for estimating the viable cells density as colony forming units (CFUs) present in 
fresh media. Control plates with PBS and agar without E.coli were performed to assess any 
contamination at this stage. 
2.4. Microcapillary E.coli capture and flow experiments using LSCM 
Confocal microscopy experiments were carried with LSCM (Nikon inverted Microscope 
ECLIPSE TE300 with Bio-Rad RAD200 (scan head 60X-1.20NA objective lenses, excitation 
peak wavelength of 488 nm and emission peak wavelength of 530 nm) operating Laser Sharp 
2000 software. Post-acquisition and particle tracking analysis were carried out using Image J 
[29]. For affinity capture of E.coli in the microcapillaries, E.coli was stained fluorescently with 
LIVE/DEAD® BacLight™ Bacterial Viability Kit according to supplier specifications for live cells. 
For each experiment, a 80 cm long MCF strip was coated with 40 μg/ml of polyclonal anti-
E.coli antibody (capAb) in PBS 0.01 M during 2 hours and Protein Free (TBS) blocking buffer 
for another 2 hours. We used pushed-fit seals to connect MCF strips to a Terumo Syringe 2.5 
6
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𝝉𝒘 = 𝝁 × ?̇? (3) 
?̇? = 
𝝏𝒖 
𝝏𝒙 
(4) 
𝜕𝑢 
where 
𝜕𝑥 
is the velocity gradient across the microcapillary. 
2.5. Study of E. coli binding into MCF capillaries with SEM 
ml luer Lock (Figure 1D) to promote a uniform filling of the microcapillaries. Flow experiments 
were performed using a PHD-ultra Harvard Pump syringe (Instech Laboratories, Inc., USA) 
and all MCF strips positioned flat in LSCM window with a built-for-purpose MCF holder. 
Because of the small dimensions of the capillaries, flow was assumed laminar and therefore 
characterized by low Reynolds number described by: 
𝑹𝒆 = 
𝝆.𝒅𝒉.𝒖 (1) 
𝝁 
where ρ (Kg/m3) is the fluid density, u (m/s) the superficial flow velocity of the fluid, μ (Ns/m2) 
the fluid viscosity and dh the mean hydraulic diameter of capillary. The volumetric flow rate,𝑄 
(m3/s) affects the superficial flow velocity, u of bacterial cells in the capillaries, according to: 
𝑸 = 𝒖. 𝑨 (2) 
where A (m2) is the cross-sectional area. It can be shown the (maximum) wall shear stress, 𝜏𝑤 
(Pa) and shear rate, ?̇? (s-1) are given, respectively by: 
We used a JSM-7800F Field Emission SEM to observe surface bound E.coli incubated in 
MCF strips with and without antibody coating. Polyclonal anti-E.coli antibody (40 μg/ml capAb) 
in PBS 0.01M was immobilized in a 50 cm long MCF strip and incubated for 2 hours and then 
further 2 hours with Protein Free TBS blocking buffer. Fluid aspiration was done with 1ml 
syringes connected to the MCF via a 2 cm long silicone tube. As controls we incubated a 20 
cm long MCF strip with the same concentration of capAb in PBS but without blocking buffer 
and a 20 cm long MCF strip with just Protein Free TBS blocking buffer during 2 hours without 
any capAb. Thereafter all strips were washed with PBS 0.05% v/v Tween-20 and trimmed into 
shorter, 10 cm long strips. Each strip was then incubated with 200 μl of a synthetic sample 
consisting of 109 CFU/ml E.coli in PBS for 20 minutes and then gently washed with 1ml PBS 
0.05% v/v Tween-20 buffer and dried at room temperature during 24 hours. One of the strips 
was incubated with 200 μl of 109 CFU/ml of E.coli in 2.5% w/v glutaraldehyde in 0.01M PBS 
and washed consequently. Before SEM imaging cell MCF strips were sliced through the middle 
of the capillaries aiming to expose the E.coli on the microcapillary walls. Samples were fixed 
to a pin stub with double-side tape and coated with 5 nm layer of gold using Au-Sputter Coater 
Quorum Q150T ES for 90 seconds. 
7
2.6. Avidity of antibody-coated microcapillaries 
A 80 cm long MCF strip was first coated with 40 µg/ml of capture for 2 hours, followed by 
blocking buffer solution for another 2 hours and finally flushed with washing buffer and trimmed 
to produce individual 40 cm long strips. Each 40 cm long strip (having a total internal volume 
of 133 l) was then gently flushed with 1.2 ml E.coli sample and incubated for 20 min with a 
10-fold serial dilution from 2 ml aliquots of E.coli samples in PBS. The solution from each strip 
was then fully recovered into a microwell by pushing the fluid out of the capillaries with a plastic 
syringe full or air attached to a 2 mm i.d. silicone tube and platted for CFU counting. The ratio 
between the CFU/ml in the recovered solution and the CFU/ml in the incubated solution 
enabled plotting the equilibrium curve and computing the percentage of CFU captured in the 
MCF strips coated with capAb with a simple mass balance. Assuming bacteria capture only 
occurred during batch incubation of the strips, it can be shown that in equilibrium conditions 
the CFUs/ml captured is given by the difference between CFU/ml in the aliquot and the 
CFUs/ml in the solution withdrew from the microcapillaries. In order to understand the effect 
of washing on bacterial binding, similar experiments were repeated at same conditions but 
adding a final step of washing with 200 μL PBS with 0.05% v/v Tween-20. 
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As CFUs/ml tested covered several orders of magnitude, results were plotted as log10 
CFU/ml and log10 CFU/cm2, the last based on an inner surface area of 25.84 cm2 for 40 cm 
long strip. As a guideline, we estimated a full monolayer capacity of 4.5×104 CFUs/ml 
assuming each E. coli cell has a footprint of 0.5 μm2 when lying in a flat position. As antibody-
cell interaction is likely to involve more than one antibody molecule, the equilibrium can be 
regarded as a representation of the binding avidity to capAb immobilized onto FEP-Teflon 
microcapillaries. 
2.7. Immunoassay detection of E.coli K12 and Bacillus subtillis 
To demonstrate immunospecificity of the immobilized capAb in respect to E. coli capturing, 
a colorimetric sandwich immunoassay was devised in the MCF strips inspired on 
immunoassay protocol previously reported by e.g. Castanheira et al. [26] for protein 
biomarkers. We used the following work assay conditions: 40 μg/ml unconjugated polyclonal 
capAb in 0.01M PBS incubated for 2 hours; 1ml Protein Free TBS blocking buffer incubated 
for another 2 hours; 150 µl of E.coli K12 or Bacillus subtillis diluted in 3% of BSA incubated for 
30 min; 40 μg/ml biotinylated detection antibody incubated for 3 min; 4 μg/ml of HSS-HRP 
incubated for further 4 minutes; chromogenic substrate consisting of 4 mg/ml OPD in 1mg/ml 
H2O2. The antibody manufacturer reported the possibility of some cross reactivity with other 
bacteria in particular related enterobacteriaceae, in this case we selected Bacillus subtilis for 
being a common, gram-positive bacteria. 
8
3. Results and discussion 
3.1. LoD of bacteria is set by level of miniaturization 
We noticed the LoD of bacteria is intrinsically linked to the level of miniaturisation. The 
advantages of microfluidic bioassays are well understood and explained in literature, however 
detection and quantitation of bacteria is intrinsically more challenging in miniaturised systems 
because of the small volumes being dealt with. The volumes herein mentioned could refer to 
the sample volumes and/or interrogation volume. The most sensitive theoretical technique will 
allow detecting just 1 CFU, however this represents a minimum volume of 1 L for a LoD of 
1×103 CFUs/ml, typically the clinical threshold for Urinary Tract Infections (UTIs) [30]; note 
counting viable cells as CFUs is a norm in microbiology as it reflects the uncertainty connected 
to visual detection of a colony resulting from a single cell or group of cells. To illustrate this, 
we have imaged plastic microcapillaries strips loaded with a serial dilution of fluorescently 
labelled E.coli in PBS into a confocal microscope. For optimum sensitivity and resolution, we 
have set the interrogation window to be 200×200 m2, representing an estimated interrogation 
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volume of just 62.5 nL for a 200 m perfectly cylindrical capillary which is a fair approximation 
for the MCF. 
Figure 2A shows a rapid drop of fluorescence signal as cells are diluted, suggesting it is not 
possible to directly quantify E.coli cells below 104 CFUs/ml even with a sophisticated 
microscope. We used ImageJ to count the number of cells that could be detected in the 
interrogation window and established a relation to the theoretical number of bacteria expected 
to be found in that volume (Figure 2B). We estimated a minimum log10 CFUs/ml of 5.20 
required to have at least one CFU present in that small interrogation volume and that becomes 
experimentally visible. This finding shows that even the most advanced optical imaging 
equipment is unable to detect anything below 4-5 log10 CFUs/ml in a synthetic sample. We 
hypothesised the use of an ‘open microfluidic’ system as exemplified by Figure 1E like the 
MCF, enabling parallel replicas and cells capturing via immobilized high affinity antibodies, 
would offer the opportunity to combine within a single device capturing and quantification of 
bacteria cells with a level of amplification, enabling the use of large sample volume for yielding 
detection at reduced CFU/ml values. 
3.2. SEM evidence of immune affinity of E.coli cells in microcapillaries. 
We studied the capture of E.coli cells in microcapillaries coated with polyclonal antibodies 
by SEM and main results are summarized in Figure 3. All MCF strips were flushed with 1 ml 
of washing solution to remove any unbound cells before imaging. We confirmed E.coli is 
unable to adhere non-specifically to raw, hydrophobic microcapillaries uncoated with capAb or 
9
in absence of blocking buffer (Figures 3A and 3B). Figures 3C-F revealed E.coli binding only 
occurred in microcapillaries coated with capAb, with Figures 3C and 3D showing detailed 
morphology between cells commensurate with the typical size for E.coli. This agreed with e.g. 
Chang et al. [9] who reported binding of E.coli DH5α and O157:H7 to the surface of the AMP-
labelled beads with similar morphology and shape [9]. The SEM study highlighted an important 
role of gravity in the capture of E.coli cells, with Figures 3E and 3F showing very distinct 
degrees of bacteria capture between the top and bottom parts for a given capillary cut along 
its length. These optical observations of uneven E.coli capture in microcapillaries are original 
and to our knowledge not previously reported in the literature, yet they can have high relevance 
to the design of fluidic devices suited to efficient capture of bacteria cells. Conventional 
microfluidic devices are usually only coated with antibody in one surface, in contrast to the 
cylindrical microcapillaries. In spite of all cross section of capillaries being evenly coated with 
the capture antibody [24], settling created a gradient of concentration reducing density of 
bacteria in the top part of the capillary and consequently increasing efficiency of cells captured 
at bottom part of the capillary. 
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3.3. Study of E.coli capture with fluorescence techniques 
LSCM experiments enabled studying the spatial and time-lapse immunocapture of 
fluorescently labelled E.coli (108 CFU/ml in 0.01M PBS) in the plastic microcapillaries. We 
initially used MCF strips in the absence of flow (to avoid blurring microphotographs) and 
samples incubated between 5 and 20 min without any subsequent washing. Figure 4A shows 
a z-stack series of fluorescently labelled E.coli cells in a random microcapillary, starting from 
bottom to the centre of microcapillary. We noticed a gradient of cells captured, with higher 
density of bacteria measured at the bottom part of the capillary in line with SEM data reported 
in section 3.2, as a result of bacteria settling during the incubation of E.coli sample (Figure 4C). 
We hypothesized gravity settling enhanced the overall capturing of cells within the 
microcapillaries. To validate this we carried out a series of in-flow capture experiments of E.coli 
at very low flow rate or 1 μl/ml. Note this corresponds to the total flow rate split between the 
10-bore MCF strip, and we assumed an even flow distribution between the 10 parallel 
microcapillaries. Figure 4B (i) shows a time sequence at four different z heights; film files are 
provided as Supplementary Information and further explained in Appendix A. We then used 
image analysis to determine the fraction of E.coli cells that remained mobile between 
consecutive frames (i.e. cells not captured by capAb immobilized) and the fraction E.coli cells 
that remained static (therefore captured) by the coated microcapillaries, these are summarised 
in Figures 4B (ii) and 4B (iii), respectively. In general, we observed a decrease on the surface 
density of cells captured with the increasing z position in the capillary, confirming the relevant 
role of gravity and suggesting cell capture is more effective at higher cell densities. 
10
Park et al. [33] demonstrated a strip-based biosensor using ELISA and monoclonal 
antibodies as immunocapture probes to quantify E.coli O157:H7 diluted in PBS buffer after 30 
min from a range CFU/ml of 1.8x103-1.8 x108. Jayamohan et al. [34] reported immunomagnetic 
separation (IMS) of E.coli O157:H7 in a range of 3-300 CFU per 100 ml of PBS buffer in 2 hr, 
with 95% extraction efficiency. Naja et al. [35] proposed capture and detection of E.coli 
suspended in PBS, using magnetic immune-nanoparticles. The immunoseparation was 
assured by attaching specific anti-E.coli polyclonal antibodies to the nanoparticles achieving 
an overall 82% yield. Wang et al. [36] validated a multiplex quantum dot-based immunoassay 
to separate foodborne pathogens (E.coli O157:H7, Salmonella Typhiurium and L. 
monocytogens) resuspended in PBS buffer with 82-90% capture efficiencies, however the 
immunoseparation process took 2hr overall for a bacterial level range of 10 to 103 CFU/ml. 
Furthermore Tu et al. [37] emphasized the importance of sedimentation and motion of 
immunobeads in respect to improving the efficiency of bacterial capture, which is in line with 
the role of gravity settling for cells retained within capillaries in our approach. Although those 
authors have attempted the immunocapture/separation, they did not address the 
miniaturization challenges and presented complex and lengthy preparation steps not suitable 
for POC applications in contrast to our proposed approach. 
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Note that immunocapturing of cells as presented in this work is unable to distinct between 
viable and dead cells in contrast to e.g. microbiological cells culturing, however clinical 
samples of active infections tend to have a very high fraction of viable cells (and in case of E. 
coli only live cells remain mobile). This disadvantage of our methodology based on capturing 
bacterial cells in plastic microcapillaries is surpassed by several advantages compared to other 
methods. For example, the gold standard method for diagnosis of UTI is entirely based on 
microbiological plate culture, requiring a trained microbiologist therefore totally limited to 
laboratory setting [3,4,7]. Urine samples are presented with unknown cell density, requiring 
the need to plate a whole dilution series. The procedure can be cost-efficient but is very slow, 
requiring 2-3 days for counting CFUs [2,4,5]. More modern procedures including enzyme 
amplification and polymerase chain reaction (PCR) are also complex in terms of fluid handling, 
requiring enriched samples and pre-selective steps [2, 4, 7, 21], therefore financially un­
attractive and restricted to analytical labs. Fluorescence cell sorting or flow cytometry is an 
effective method for counting cells yet it requires fluorescent labelling and separation of cells 
(which can be done with e.g. magnetic-activated cell sorting), therefore the method is complex 
and again limited to lab setting. Immunoassay methods based on plastic surfaces coated with 
specific capturing antibodies are widely accepted including at point-of-care and sensitive for 
bacterial detection. 
We imaged all capillaries on a given MCF strip (results not shown) and in general observed 
a small variation (dh = 206 ± 12.6 μm) between the capillaries in the middle of the strips and 
11
those at the edges [23,31]. This is due to a 6% of variation on dh for each capillary across the 
strip inherent from the melt extrusion fabrication process. According to Haggen-Poiseuille’s 
equation pressure drop is proportional to (dh)4 a significant variation in flow distribution and 
mean residence time of the sample across all MCF strips [31]. We tracked individual cells in 
the in-flow experiments of confocal imaging in-flow to determine the velocity profile of E. coli 
cells flowing along the straight microcapillaries. Note the magnification used in the confocal 
imaging aimed maximum resolution, therefore a small field of view of just 200×200 m2 was 
used. All experimental data was collected assuming as reference capillary number 5 (at centre 
of MCF). We noticed higher bacteria velocities at the centre of the capillary, and negligible as 
it approached the walls, agreeing with parabolic velocity profile characteristic of laminar flow 
in microcapillaries (Figure 5) and described by: 
𝟐𝒓
𝒖(𝒓) = 𝒖𝒎𝒂𝒙 × [𝟏 − ( ) ] (6) 𝑹
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where u(r) (µm/s) is the superficial flow velocity at radial position r (µm) estimated, umax (m/s) 
the maximum flow velocity achieved in centre of capillary, and R (µm) the radius of the capillary 
(we assumed R = dh/2). We estimated a maximum fluid velocity in the centre of the wall 
capillary of 53 µm s-1 and wall shear rate of 101 s-1. We observed a degree of flow focusing, 
with cells preferring to flow through the centre of the capillary, corresponding to streamlines 
with reduced shear rate therefore reduced resistance. This focusing of cells in microcapillaries 
has a large implication in antibody capture of cells by reducing the probability of cells 
interacting with the wall and being captured by antibody immobilized at the wall, this 
observation is very relevant to any method replying on wall immobilization of antibody for 
quantitation and capture of bacteria. The maximum velocity of bacteria was always observed 
to be lower (on average 40-50%) than the estimated core fluid velocity. This was consistent 
across multiple replicas and is presumably indicative of mobility of E.coli cells. According to 
Wioland et al. [32], E.coli trends to walls, however in presence of continuous flow they follow 
the orientation direction of fluid flow. Those are consistent with our LSCM observations. 
3.4. Capturing equilibrium and immunospecificity of antibody-bacteria binding 
We studied the equilibrium and efficiency of E.coli capture in MCF strips coated with 
immobilized capAb and incubated with E. coli samples for 20 min (Figure 6). All experimental 
runs were duplicated and values quantified with a standard deviation within 5%. Note that a 
capillary entirely coated with capAb presents a SAV ratio 4 times larger than the one obtained 
by coating just one surface in a microchannel with the same dimensions, so the cylindrical 
shape of the microcapillaries offers larger surface for capturing cells but also helps pushing 
the equilibrium towards bacteria-capAb complex formation. 
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All independent experimental runs 1 to 3 (without washings) and run 4 (with washing) 
showed a great consistency with a cross-correlation coefficient of R2 > 0.9973, with both 
CFU/ml and CFU/cm2 increasing linearly with enhancing bacteria loading, up to 6 orders of 
magnitude beyond the CFU/ml estimated from a full monolayer (4.5 log10 CFU/ml). The 
equilibrium plot showed bacteria capturing as a first order process with no clear trend in 
respect to saturation of the surface in the whole window of concentration tested (up to 1012 
CFUs/ml). The efficiency for E.coli capturing was 100% for small values of CFU/ml (up to 2-3 
log10) and followed an exponential decay with increasing CFU/ml in the incubated sample, 
however surprisingly it remained meaningful for the whole range of CFU/ml tested. For the 
range relevant to UTIs (up to 108 CFUs/ml), the capturing remained between 100 and 20% 
with just 20 min incubation, so in alignment with the capturing yields reported by e.g. Naja et 
al. [35] and Wang et al. [36]. 
The bacteria capturing resulted from a combination of immunoaffinity capturing by the 
immobilized capAb and gravity settling of cells within the microcapillaries. The last was 
especially noticeable at high cell densities and presumably linked to aggregation of E. coli cells 
which is widely reported in literature. Confocal imaging experiments summarised discussed in 
section 3.3 showed settling of E. coli cells occurred within few minutes, and definitely within 
the 20 min incubation time used for these set of experiments. Although the lowest CFUs/ml 
tested was 148 (equivalent to 2.15 log10), the plots in Figure 6 suggest our approach for 
immunocapturing of E. coli is 100% efficient at very low CFUs/ml, representing a limit of 
detection of at just 1 CFU (equivalent to 7.5 CFU/ml for a 40 cm long MCF strip). Based on 
the correlation presented for the CFU/ml vs CFU/cm2 plot, with a cross-correlation coefficient, 
R2 = 0.9973, the capturing of 1 CFU (equivalent to 0.04 CFU/cm2 on the y axis) occurs at 10 
CFU/ml in solution (x axis), which means 1 CFU for the volume of MCF used (133 l), 
confirming the best possible limit of detection. 
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Run 4 aimed testing the effect of adding a washing step with 0.05% w/w Tween 20 in PBS 
for separating bound from unbound cells following incubation of sample with bacteria, and 
showed negligible effect of washing at higher cell densities. In spite of a 62-fold difference in 
diameter for an IgG antibody molecule (160 Angstroms) [38] and E. coli cell (between 0.5 and 
5 µm) [37], cells capturing revealed resistant to fluid shear given by equations (3)-(4). 
Although a methodology for bacteria capturing relying on gravity as the one proposed in 
this work can sound unpredictable and inaccurate, the data from independent experimental 
runs demonstrate this method is very reproducible. It is however not possible at this stage to 
comment on whether this methodology shows any level of selectivity to enable its use for 
separation of cells or capturing of cells from mixed cultures. This will be subject of future 
studies. 
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We tested the immunospecificity of coated microcapillaries for E.coli capture by carrying 
out a sandwich immunoassay amplification following a step of immunocapture of bacteria 
sample. Figure 7 shows the polyclonal antibody (specific to K and O serotypes of E .coli) 
demonstrated specificity for capturing E.coli (gram-negative) when tested bacterial samples of 
Bacillus subtillis (gram-positive) suspended in PBS 0.1M buffer. Statistically, no significant 
difference was observed in the absorbance signal obtained for the sandwich immunoassays 
incubated with Bacillus subtillis and PBS buffer (negative control), however it should be noted 
that the immunoassays were carried at very high cell densities and the signal shown by 
Bacillus sp. will drop as cell density decreases. Also, Bacillus sp. are not present in UTI 
infections. ‘Sanvicens et al. [39] have used the same set of polyclonal antibodies for a quantum 
dot-based array for sensitive detection of E.coli O157:H7 and reported a negligible interference 
with pathogenic S. aureus (gram- positive) and P. aeruginosa (gram-negative) at low cell 
densities. The cross-reactivity of the antibodies should ideally have been tested against all the 
most common bacterial strains present in urine samples, which according to the European 
guidelines for urinalysis [40] are Enterobacter spp., Enterococcus spp., Klebsiella spp., 
Proteus mirabilis and Pseudomonas aeruginosa (majority enterobacteriacea), however any 
limitations with cross-reactivity of antibodies can be solved by using more specific, monoclonal 
antibodies for capturing and/or detection stages. Cross-reactivity of capture antibody with 
other species can actually be an advantageous feature for offering identification of multiple 
bacteria strains with a single capture antibody. A comprehensive cross-reactivity study will be 
the focus of future studies. It is common for some polyclonal antibodies to show cross-reactivity 
with other species, this will need to be fully examined using pure and mixed cultures before 
implementation of this method into an actual diagnostic test. Nevertheless, this new data 
related to immunocapturing is believed very useful for future developments of rapid test for 
UTIs, from clinical samples likely to contain pathogenic and non-pathogenic bacteria. 
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4. Conclusions 
This experimental study has demonstrated efficient capturing of E.coli in plastic 
microcapillaries enabled by a combination of immunocapturing via an immobilized polyclonal 
antibody against E.coli and gravity settling, as evidenced by a range of optical imaging 
techniques. MCF platform showed immunospecificity for capturing E.coli K12 cells and high 
‘affinity’ of capturing, with 100% capturing efficiency at 102 CFUs/ml. This study also 
highlighted the importance of interrogation volume in respect to the minimum CFUs/ml that 
can be detectable which intrinsically sets the limit of detection and the development of rapid 
miniaturised immunoassays based on affinity capturing of bacteria. Washings are an important 
feature in high-performance heterogeneous immunoassays (utilising immobilized antibodies), 
therefore the washing resistant cell capturing herein reported open up the opportunity to 
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integrate cells capturing with antibody and enzymatic labelling for quantitation of cells in future 
works. These new insights into microfluidic capture of E.coli are believed to be a major step 
towards the development of rapid immunoassay-based POC tests for quantitation of E.coli and 
other microbial pathogens. This method for capturing bacterial cells can certainly be applied 
to capture and eventually separation of other bacteria strains, to be subject of future 
publications. 
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Figure captions 
Figure 1 Fluoropolymer MCF platform and accessories used to carry out in-flow LSCM 
experiments. A Top view of MCF strips. B Cross section photograph of a 10 bore MCF. C MCF 
accessories used in LSCM: 1 - MCF fitting connected to the luer with lock syringe, 2 - MCF 
holder capable of holding several MCF parallel MCF strips. D MCF accessories to connect 
MCF strips to Harvard Pump: 1 - MCF fitting with female luer, 2 - MCF male fitting, 3 - Push­
fit seal, 4 - Terumo Syringe 2.5 ml luer lock. E ‘Open fluidics’ design of microcapillaries that 
enable passing a large volume of sample through the microcapillaries with immobilized capAb. 
Figure 2 LSCM imaging of fluorescently labelled E.coli in a plastic microcapillary. A Serial 
dilution of E.coli in PBS imaged in a 200×200 m2 section of a 200m i.d microcapillary. B 
Relationship between theoretical and experimental CFUs in interrogation volume (estimated 
as 62.5 nL). 
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Figure 3 SEM microphotographs of inner wall of fluoropolymer MCF microcapillaries. A MCF 
strip coated with blocking buffer solution and then incubated with synthetic sample B Uncoated 
MCF strip incubated only with synthetic sample. C and D MCF strips coated with capture 
antibody, blocking buffer solution and synthetic sample, showing size and morphology of E.coli 
cells. E and F Detail of top half and bottom half of the same microcapillary coated with capAb, 
blocking buffer solution and incubated with synthetic sample, revealing bacteria binding is not 
spatially uniform in horizontal capillaries. 
Figure 4 LSMC imaging of E.coli cells in plastic microcapillaries coated with polyclonal anti-
E.coli antibody. A z-stack series of MCF strip coated with 40 µg/ml capAb and blocking solution, 
and incubated for 5 min (in continuous flow) with a synthetic sample of E.coli stained 
fluorescently in 0.01M PBS. Sequence shows confocal images from bottom of capillary, z 
position = 35 m (left) towards the middle of capillary, z position = 100 m (right). B In-flow 
capture of E.coli cells, total flow rate of 1 µl/min (for 10-bore MCF), (i) snapshot of time 
sequenced films imaged at 4 fixed z positions as provided in Supplementary Information in 
Appendix A. Snapshot shows last frame in time sequence; for each stack two consecutive time 
frames were subtracted yielding in (ii) the cells that remained mobile (i.e. not captured by 
capAb) and in (iii) bacteria cells successfully captured. C log10 total cells and cells captured in 
interrogation window with z position in capillaries. 
Figure 5 Speed velocity of bacteria flow in microcapillary number 5 versus normalized radial 
position, for rate of 1l/min in the 10-bore MCF. Individual E.coli cells were tracked in two 
separate runs (1 & 2) and the mean velocity plotted. 
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Figure 6 Equilibrium of E.coli capturing in the MCF coated with polyclonal antibody based on 
3 independent, experimental replicates without (run 1-3) and with (run 4) sample washing. Full 
monolayer capacity was based on footprint of individual E.coli cells. Results are plots as 
CFU/ml and CFU/cm and efficiency of capturing showing coated capillaries are particularly 
efficient capturing E.coli at low cell densities and washings had no detectable effect in reducing 
cells capture efficiency, validating immunocapture of polyclonal capture antibodies 
Figure 7 Colorimetric sandwich immunoassay showing immunospecificity of cells captured in 
microcapillaries using 108 CFU/ml of E.coli K12, Bacillus subtillis and buffer diluent (0.01M 
PBS).
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